Merck spends $10 billion for Verona, gaining access to its COPD medication

bostonherald.com/2025/07/09/merck-verona

By MICHELLE CHAPMAN
Pharmaceutical giant Merck is buying Verona Pharma, a company that focuses on respiratory diseases, in an approximately $10 billion deal.
Related Articles



Trump hits Brazil with 50% tariffs






Report: Would-be Boston WNBA ownership group spokesman…

This story appeared on bostonherald.com, 2025-07-09 21:24:48.
The Entire Business World on a Single Page. Free to Use →